Feb 28, 2024   SOURCE: PR Web

Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements

The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates REHOVOT, Israel, Feb. 28, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and...

View source version on PR Web: https://www.prweb.com/news-releases/lavie-bio-successfully-secures-second-half-advance-payment-of-2-5m-after-meeting-cortevas-licensing-agreement-requirements-302074094.html